118 related articles for article (PubMed ID: 36999423)
1. Computer-aided Drug Discovery Approaches in the Identification of Natural Products against SARS-CoV-2: A Review.
Junqueira Ribeiro MM
Curr Comput Aided Drug Des; 2024; 20(4):313-324. PubMed ID: 36999423
[TBL] [Abstract][Full Text] [Related]
2. Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies.
Khursheed A; Jain V; Rasool A; Rather MA; Malik NA; Shalla AH
Microb Pathog; 2021 Aug; 157():104933. PubMed ID: 33984466
[TBL] [Abstract][Full Text] [Related]
3.
Rahman MM; Islam MR; Akash S; Mim SA; Rahaman MS; Emran TB; Akkol EK; Sharma R; Alhumaydhi FA; Sweilam SH; Hossain ME; Ray TK; Sultana S; Ahmed M; Sobarzo-Sánchez E; Wilairatana P
Front Cell Infect Microbiol; 2022; 12():929430. PubMed ID: 36072227
[TBL] [Abstract][Full Text] [Related]
4. Natural Products with Tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 Effects: A Drug Discovery Perspective against SARS-CoV-2.
da Cunha LNOL; Tizziani T; Souza GB; Moreira MA; Neto JSS; Dos Santos CVD; de Carvalho MG; Dalmarco EM; Turqueti LB; Scotti MT; Scotti L; de Assis FF; Braga AL; Sandjo LP
Curr Med Chem; 2022; 29(14):2530-2564. PubMed ID: 34313197
[TBL] [Abstract][Full Text] [Related]
5. Natural Products as Potential Agents against SARS-CoV and SARSCoV- 2.
Raimundo E Silva JP; Acevedo CAH; de Souza TA; de Menezes RPB; Sessions ZL; Abreu LS; Cibulski SP; Scotti L; da Silva MS; Muratov EN; Scotti MT; Tavares JF
Curr Med Chem; 2021; 28(27):5498-5526. PubMed ID: 33550959
[TBL] [Abstract][Full Text] [Related]
6. An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.
Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
Biomed Res Int; 2021; 2021():8853056. PubMed ID: 34258282
[TBL] [Abstract][Full Text] [Related]
7. Identification of terpenoids as potential inhibitors of SARS-CoV-2 (main protease) and spike (RBD) via computer-aided drug design.
Hadni H; Fitri A; Touimi Benjelloun A; Benzakour M; Mcharfi M; Benbrahim M
J Biomol Struct Dyn; 2023 Aug; ():1-14. PubMed ID: 37548619
[TBL] [Abstract][Full Text] [Related]
8. In Silico Models for Anti-COVID-19 Drug Discovery: A Systematic Review.
Onyango OH
Adv Pharmacol Pharm Sci; 2023; 2023():4562974. PubMed ID: 37362912
[TBL] [Abstract][Full Text] [Related]
9. In silico approach of secondary metabolites from Brazilian herbal medicines to search for potential drugs against SARS-CoV-2.
Amparo TR; Seibert JB; Almeida TC; Costa FSF; Silveira BM; da Silva GN; Dos Santos ODH; de Souza GHB
Phytother Res; 2021 Aug; 35(8):4297-4308. PubMed ID: 33797123
[TBL] [Abstract][Full Text] [Related]
10. Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological Aspects.
Gentile D; Patamia V; Fuochi V; Furneri PM; Rescifina A
Curr Med Chem; 2021; 28(40):8333-8383. PubMed ID: 34126880
[TBL] [Abstract][Full Text] [Related]
11. Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies.
Skariyachan S; Gopal D; Muddebihalkar AG; Uttarkar A; Niranjan V
Comput Biol Med; 2021 May; 132():104325. PubMed ID: 33751995
[TBL] [Abstract][Full Text] [Related]
12. Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection.
Prasansuklab A; Theerasri A; Rangsinth P; Sillapachaiyaporn C; Chuchawankul S; Tencomnao T
J Tradit Complement Med; 2021 Mar; 11(2):144-157. PubMed ID: 33520683
[TBL] [Abstract][Full Text] [Related]
13. In silico evaluation of food-derived carotenoids against SARS-CoV-2 drug targets: Crocin is a promising dietary supplement candidate for COVID-19.
Mujwar S; Sun L; Fidan O
J Food Biochem; 2022 Sep; 46(9):e14219. PubMed ID: 35545850
[TBL] [Abstract][Full Text] [Related]
14.
Sureja DK; Shah AP; Gajjar ND; Jadeja SB; Bodiwala KB; Dhameliya TM
ChemistrySelect; 2022 Jul; 7(28):e202202069. PubMed ID: 35942360
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An
Behera SK; Mahapatra N; Tripathy CS; Pati S
Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):132-143. PubMed ID: 33818470
[TBL] [Abstract][Full Text] [Related]
16. Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 M
Mohan A; Rendine N; Mohammed MKS; Jeeva A; Ji HF; Talluri VR
Mol Divers; 2022 Jun; 26(3):1645-1661. PubMed ID: 34480682
[TBL] [Abstract][Full Text] [Related]
17. An integrated computational approach towards the screening of active plant metabolites as potential inhibitors of SARS-CoV-2: an overview.
Kushari S; Hazarika I; Laloo D; Kumar S; Kalita JM; Sarma H
Struct Chem; 2023; 34(3):1073-1104. PubMed ID: 36212707
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning.
Kadioglu O; Saeed M; Greten HJ; Efferth T
Comput Biol Med; 2021 Jun; 133():104359. PubMed ID: 33845270
[TBL] [Abstract][Full Text] [Related]
19. Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates.
Serafim MSM; Gertrudes JC; Costa DMA; Oliveira PR; Maltarollo VG; Honorio KM
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33624754
[TBL] [Abstract][Full Text] [Related]
20. Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective.
Aggarwal V; Bala E; Kumar P; Raizada P; Singh P; Verma PK
Curr Top Med Chem; 2023; 23(17):1664-1698. PubMed ID: 36974409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
